The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer.
Ablinger C, Neureiter D, Mähr T, Mayr C, Kiesslich T, Maeding N, Valenta I, Ardelt M, Wilhelm F, Neureiter E, Ritter M, Pachmayr J, Huber-Cantonati P.
Ablinger C, et al. Among authors: valenta i.
Cancer Biol Ther. 2024 Dec 31;25(1):2439057. doi: 10.1080/15384047.2024.2439057. Epub 2024 Dec 12.
Cancer Biol Ther. 2024.
PMID: 39668430
Free article.